This Edition
ARTICLE | Clinical News
Topsalysin: Phase IIa started
WIR Staff
June 8, 2015 7:00 AM UTC
Sophiris began an open-label, U.S. Phase IIa trial to evaluate PRX302 in about 20 patients. ...